Key result
Charge density mapping-guided ablation is linked to ~79% less post-surgical atrial tachycardia recurrence versus CARTO.
Why the study?
Atrial tachycardia frequently occurs after cardiac surgery, and whether novel charge density-based mapping is safe, feasible, and improves catheter ablation outcomes compared to conventional sequential 3D mapping was unknown.
Does catheter ablation guided by charge density mapping improve outcomes and reduce recurrences in patients with post-surgical atrial tachycardia compared to conventional sequential 3D mapping?
Observational (n=35)
No
Does catheter ablation guided by charge density mapping improve outcomes and reduce recurrences in patients with post-surgical atrial tachycardia compared to conventional sequential 3D mapping?
Absolute Event Rate: 95% vs 73.3%
p-value: p=0.14
Charge density mapping-guided catheter ablation for post-surgical atrial tachycardia is safe, feasible, and significantly reduces 12-month arrhythmia recurrence compared to conventional 3D mapping.
May support charge density mapping in post-surgical AT ablation; leaves open need for randomized confirmation.
Introduction Atrial tachycardia (AT) frequently occurs after cardiac surgery or surgical ablation procedures. The novel charge density-based mapping system (CDM) provides global chamber mapping and can detect crucial pathways of conduction; therefore, it has potential added value in catheter ablation (CA) of post-surgical ATs. We aimed to test the hypothesis that CDM-guided CA procedures are safe, feasible, and may improve outcome compared to conventional sequential 3D mapping (CARTO)-based CA. Methods and results Consecutive patients undergoing CA for post-surgical AT guided by CDM or CARTO were enrolled. Procedural safety and efficiency were analyzed. Acute success, one-year outcome was assessed. A total of 35 patients (mean age 60.8 ± 10.6 years, 42.9% female) underwent CA of AT using CDM ( n = 20) and CARTO ( n = 15). A total of 61 ATs were mapped (35 in CDM and 26 in CARTO group). Four patients had focal ATs, 22 macro re-entrant, and 8 patients had ATs with both mechanisms. No differences were found in procedural complication (CDM 3 vs. CARTO 1 patient, p = 0.61). There were no differences in procedure duration (185.9 vs. 147.9 min, p = 0.09), fluoroscopy dose (165.0 vs. 155.0 mGy, p = 0.31), RF application number (28.0 vs. 18.0, p = 0.17) or duration (1,251.5 vs. 1,060.0 s, p = 0.54). Acute success was 95.0% in CDM and 73.3% in CARTO group ( p = 0.14). Cumulative AT recurrence rates were lower in CDM group compared to CARTO group (10.0% vs. 46.7%, p = 0.02). Conclusions The CDM system is feasible. Our data suggest that patients treated with CDM-guided CA developed fewer AT recurrences as compared to CARTO-guided procedures.
No takes yet. Share an insight, caveat, or question.
Gagyi et al. (2024) conducted an observational in Post-surgical atrial tachycardia (n=35). Charge density mapping (CDM) guided catheter ablation vs. Conventional sequential 3D mapping (CARTO) guided catheter ablation was evaluated on Acute procedural success (p=0.14). Charge density mapping-guided catheter ablation for post-surgical atrial tachycardias was safe and feasible, significantly reducing 12-month atrial tachycardia recurrence to 10.0% compared to 46.7% with CARTO-guided procedures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: